BioVie Inc (NASDAQ:BIVI) price on Thursday, July 03, fall -1.07% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $0.96.
A look at the stock’s price movement, the close in the last trading session was $0.97, moving within a range at $0.95 and $0.9981. The beta value (5-Year monthly) was 1.149. Turning to its 52-week performance, $7.50 and $0.62 were the 52-week high and 52-week low respectively. Overall, BIVI moved -13.51% over the past month.
BioVie Inc’s market cap currently stands at around $17.83 million, with investors looking forward to this quarter’s earnings report slated for on 2024-Feb-13.
Turning to the stock’s technical picture we see that short term indicators suggest on average that BIVI is a 50% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
1 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 1 recommend BIVI as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
BIVI’s current price about -8.60% and -7.53% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 42.72, while 7-day volatility ratio is 7.77% and 6.90% in the 30-day chart. Further, BioVie Inc (BIVI) has a beta value of 1.09.
If we refocus on BioVie Inc (NASDAQ:BIVI), historical trading data shows that trading volumes averaged 0.23 over the past 10 days and 419.32K over the past 3 months. The company’s latest data on shares outstanding shows there are 18.52 million shares.
The 13.06% of BioVie Inc’s shares are in the hands of company insiders while institutional holders own 5.33% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 1.23 million on 2025-06-13, giving us a short ratio of 4.98. The data shows that as of 2025-06-13 short interest in BioVie Inc (BIVI) stood at 760.0 of shares outstanding, with shares short falling to 1.5 million registered in 2025-05-15. Current price change has pushed the stock -76.95% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the BIVI stock continues to rise going into the next quarter.
